Tirzepatide Improved Mental and Psychosocial Function in Adults with Obesity or Overweight in the SURMOUNT-3 Trial

被引：0
|
作者：
Gibble, Theresa Hunter
Cao, Dachuang
Forrester, Tammy D.
Brumm, Julia Fraseur
Chao, Ariana
机构：
来源：
DIABETES | 2024年 / 73卷
关键词：
D O I：
10.2337/db24-1676-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1676-P
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial
    Thomas A. Wadden
    Ariana M. Chao
    Sriram Machineni
    Robert Kushner
    Jamy Ard
    Gitanjali Srivastava
    Bruno Halpern
    Shuyu Zhang
    Jiaxun Chen
    Mathijs C. Bunck
    Nadia N. Ahmad
    Tammy Forrester
    Nature Medicine, 2023, 29 : 2909 - 2918
  • [2] Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity (SURMOUNT-3)
    Wadden, Thomas A.
    Chao, Ariana M.
    Machineni, Sriram
    Kushner, Robert
    Ard, Jamy
    Srivastava, Gitanjali
    Halpern, Bruno
    Zhang, Shuyu
    Chen, Jiaxun
    Bunck, Mathijs C.
    Ahmad, Nadia N.
    Forrester, Tammy
    Richardson, Emily
    OBESITY SURGERY, 2024, 34 : S34 - S34
  • [3] Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial
    Wadden, Thomas A.
    Chao, Ariana M.
    Machineni, Sriram
    Kushner, Robert
    Ard, Jamy
    Srivastava, Gitanjali
    Halpern, Bruno
    Zhang, Shuyu
    Chen, Jiaxun
    Bunck, Mathijs C.
    Ahmad, Nadia N.
    Forrester, Tammy
    NATURE MEDICINE, 2023, 29 (11) : 2909 - 2918
  • [4] Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial (vol 29, pg 2909, 2023)
    Wadden, Thomas A.
    Chao, Ariana M.
    Machineni, Sriram
    Kushner, Robert
    Ard, Jamy
    Srivastava, Gitanjali
    Halpern, Bruno
    Zhang, Shuyu
    Chen, Jiaxun
    Bunck, Mathijs C.
    Ahmad, Nadia N.
    Forrester, Tammy
    NATURE MEDICINE, 2024, 30 (06) : 1784 - 1784
  • [5] Tirzepatide Was Associated with Improved Health-Related Quality of Life in Adults with Obesity or Overweight and Type 2 Diabetes: Results from the Phase 3 SURMOUNT-2 Trial
    Theresa Hunter Gibble
    Dachuang Cao
    Xiaotian Michelle Zhang
    Neena Agarwal Xavier
    Jiat Ling Poon
    Angela Fitch
    Diabetes Therapy, 2025, 16 (5) : 977 - 991
  • [6] Tirzepatide for Weight Reduction in Chinese Adults With Obesity The SURMOUNT-CN Randomized Clinical Trial
    Zhao, Lin
    Cheng, Zhifeng
    Lu, Yibing
    Liu, Ming
    Chen, Hong
    Zhang, Min
    Wang, Rui
    Yuan, Yuan
    Li, Xiaoying
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 332 (07): : 551 - 560
  • [7] Body composition changes during weight reduction with tirzepatide in the SURMOUNT-1 study of adults with obesity or overweight
    Look, Michelle
    Dunn, Julia P.
    Kushner, Robert F.
    Cao, Dachuang
    Harris, Charles
    Gibble, Theresa Hunter
    Stefanski, Adam
    Griffin, Ryan
    DIABETES OBESITY & METABOLISM, 2025, 27 (05): : 2720 - 2729
  • [8] Tolerability and Weight Reduction of Tirzepatide in Adults With Obesity or Overweight
    Rubino, Domenica
    Pedersen, Sue
    Connery, Lisa
    Stefanski, Adam
    Cao, Dachuang
    Brumm, Julia Fraseur
    Griffin, Ryan
    Malik, Raleigh
    OBESITY, 2023, 31 : 31 - 31
  • [9] Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity (SURMOUNT-4)
    Aronne, Louis J.
    Sattar, Naveed
    Horn, Deborah B.
    Bays, Harold
    Wharton, Sean
    Lin, Wen-Yuan
    Ahmad, Nadia N.
    Zhang, Shuyu
    Liao, Ran
    Bunck, Mathijs C.
    Jouravskaya, Irina
    Murphy, Madhumita A.
    Coates, Simon
    OBESITY SURGERY, 2024, 34 : S34 - S34
  • [10] Differences in Weight Reduction Efficacy of Tirzepatide in Adults Without vs. With Type 2 Diabetes with Overweight or Obesity in SURMOUNT 1 and 2
    Galindo, Rodolfo J.
    Garvey, W. Timothy
    Neff, Lisa M.
    Stefanski, Adam
    Cao, Dachuang
    Lee, Clare
    DIABETES, 2024, 73
12345